Effect of cerebrolysin on motor function restoration during medical rehabilitation

Since it was successful in restoring motor function, HOW FUCKING LONG BEFORE IT GETS TO YOUR HOSPITAL? I'M GUESSING NEVER. 

No one in your hospital is responsible for translating research into interventions.  The board of directors and president need to be fired for such incompetence. 

Earlier research here which I'm sure they did nothing on. 

• Cerebrolysin (5 post to November 2015)
• Cerebrolysin® (1  post to June 2014)

Effect of cerebrolysin on motor function restoration during medical rehabilitation

 Влияние церебролизина на восстановление двигательной функции в процессе медицинской реабилитации.  Neurology, Neuropsychiatry, Psychosomatics , Volume 8(2) , Pgs. 80-86.

NARIC Accession Number: I245736.  What's this?
Author(s): Kustova M.A.; Tolmachev A.P; Shamalov N.A.
Publication Year: 2016.
Abstract: This paper presents the January 2016 results of the randomized placebo-controlled multicenter study Cerebrolysin and Recovery After Stroke (CARS), which demonstrates the positive effect of cerebrolysin versus placebo according to the primary efficiency criterion, the Action Research Arm Test (ARAT) scale, and total outcome 90 days after disease onset. Ischemic stroke (IS) is characterized by high prevalence, mortality, and disability rates. Therapy aimed to correct one biochemical or molecular stage of ischemic cell injury fails to treat stroke, suggesting that it is necessary to study multimodality therapy affecting several related pathophysiological components. The CARS investigation enrolled mainly patients with moderate or severe IS (the mean National Institutes of Health Stroke Scale score was 9 at baseline). The specific features of the CARS study versus those of other clinical trials of neuroprotectors were the initial planning of narrower end criteria of efficiency (arm motor function recovery, whereas the major goal of many investigations was to reduce mortality rates), as well as a standardized rehabilitation program in both treatment groups. Such investigations did not previously consider the nature and volume of rehabilitation measures, although the latter may have a substantial impact on the outcome of stroke. The CARS study is the first among the previously conducted clinical trials of neuroprotectors that has attained the primary objective (to restore motor function), which presents fresh opportunities for the medical support of rehabilitation measures in patients with IS.
Descriptor Terms: Drugs, Rehabilitation, Stroke.
Language: Russian
Geographic Location(s): Europe, Russia.

Can this document be ordered through NARIC's document delivery service*?: Request Information.
Get this Document: https://nnp.ima-press.net/nnp/article/view/613/563.

Citation: Kustova M.A., Tolmachev A.P, Shamalov N.A. (2016). Effect of cerebrolysin on motor function restoration during medical rehabilitation.  Влияние церебролизина на восстановление двигательной функции в процессе медицинской реабилитации.  Neurology, Neuropsychiatry, Psychosomatics , 8(2), Pgs. 80-86. Retrieved 11/22/2019, from REHABDATA database.